NINJ1 and Sepsis: Inhibiting NINJ1-dependent PMR protects against LPS-induced sepsis and inflammasome-induced blood coagulation and inflammation (42, 46), as well as platelet activation and PANoptosis in septic disseminated intravascular coagulation (44).